Related Experiment Video
Updated: Dec 23, 2025

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney
Published on: August 9, 2014
IgA nephropathy in children and in adults: two separate entities or the same disease?
Rosanna Coppo1, Thomas Robert2
1Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy. rosanna.coppo@unito.it.
Insights
IgA nephropathy (IgAN) presents differently in children and adults. Understanding these differences is key to determining if new adult treatments can benefit pediatric patients, potentially preventing long-term kidney damage.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Immunology
Background:
- IgA nephropathy (IgAN) affects all ages, but management differs between adult and pediatric nephrologists.
- Pediatric IgAN often presents with hematuria and rarely progresses to end-stage renal disease (ESRD) during childhood.
- Adult IgAN is typically a progressive glomerular disease with a 30-40% risk of ESRD.
Purpose of the Study:
- To review similarities and differences in IgA nephropathy (IgAN) across pediatric and adult age groups.
- To inform the application of new therapeutic strategies for IgAN across the disease spectrum.
- To determine if IgAN is a single entity or distinct clinical conditions in children and adults.
Main Methods:
- Comparative review of IgA nephropathy (IgAN) clinical presentations and progression in pediatric versus adult populations.
- Analysis of risk assessment strategies for both pediatric and adult IgAN cases.
- Evaluation of the potential applicability of adult therapeutic advancements to pediatric IgAN.
Main Results:
- IgAN exhibits varied clinical profiles in children and adults, impacting long-term prognosis.
- Early identification and risk stratification are crucial for appropriate IgAN management in all age groups.
- Delayed diagnosis in childhood IgAN can lead to irreversible damage manifesting decades later.
Conclusions:
- IgA nephropathy (IgAN) management requires age-specific considerations due to differing clinical trajectories.
- Further research is needed to ascertain if IgAN is a unified disease or distinct entities across age groups.
- Harmonizing treatment approaches based on shared risk factors may improve outcomes for both pediatric and adult IgAN patients.
Abstract:
IgA nephropathy (IgAN) is observed in subjects of any age, however perspective and management of this disease are different between adult and pediatrician Nephrologists. Most children with IgAN present with gross hematuria rapidly vanishing or persistent mild microscopic hematuria, which rarely progresses to end stage renal disease (ESRD) over the pediatric observation. The perspective of IgAN in adults is of a slowly progressive glomerular disease with 30-40% probabilities to reach ESRD. However, mild cases of IgAN in children might be missed with manifestation of irreversible damage only decades after the true onset, as 50% of subjects with IgAN enter renal replacement treatment before the age of 50 years. In both adults and children the assessment of risk profile is crucial to avoid overtreatment in benign cases or institute a prompt and valid therapy in potentially progressive cases. In case of common risk factors, new therapeutic opportunities tested in adults might be applied to children with the expectation of similar results. If IgAN is the same disease in spite of different clinical profiles in children and adults, an early intervention may be the correct way to prevent progression decades later. On the contrary, if we are dealing with different clinical entities, the treatment in pediatric and in adult settings must be kept apart. This review addresses to report similarities and differences of IgAN across the life periods in order to reason on the application of newly offered treatments over the entire spectrum of this disease or in focused age indications.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrons
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction

